1. Home
  2. RGEN vs PARA Comparison

RGEN vs PARA Comparison

Compare RGEN & PARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • PARA
  • Stock Information
  • Founded
  • RGEN 1981
  • PARA 1986
  • Country
  • RGEN United States
  • PARA United States
  • Employees
  • RGEN N/A
  • PARA N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • PARA Broadcasting
  • Sector
  • RGEN Health Care
  • PARA Industrials
  • Exchange
  • RGEN Nasdaq
  • PARA Nasdaq
  • Market Cap
  • RGEN 8.0B
  • PARA 7.9B
  • IPO Year
  • RGEN N/A
  • PARA N/A
  • Fundamental
  • Price
  • RGEN $122.52
  • PARA $11.97
  • Analyst Decision
  • RGEN Buy
  • PARA Sell
  • Analyst Count
  • RGEN 12
  • PARA 13
  • Target Price
  • RGEN $172.67
  • PARA $11.42
  • AVG Volume (30 Days)
  • RGEN 815.5K
  • PARA 7.3M
  • Earning Date
  • RGEN 04-29-2025
  • PARA 05-08-2025
  • Dividend Yield
  • RGEN N/A
  • PARA 1.70%
  • EPS Growth
  • RGEN N/A
  • PARA N/A
  • EPS
  • RGEN N/A
  • PARA N/A
  • Revenue
  • RGEN $650,429,000.00
  • PARA $28,720,000,000.00
  • Revenue This Year
  • RGEN $13.93
  • PARA N/A
  • Revenue Next Year
  • RGEN $14.35
  • PARA $1.15
  • P/E Ratio
  • RGEN N/A
  • PARA N/A
  • Revenue Growth
  • RGEN 4.88
  • PARA N/A
  • 52 Week Low
  • RGEN $102.97
  • PARA $9.54
  • 52 Week High
  • RGEN $182.52
  • PARA $13.40
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 42.15
  • PARA 56.98
  • Support Level
  • RGEN $120.11
  • PARA $11.62
  • Resistance Level
  • RGEN $129.42
  • PARA $11.89
  • Average True Range (ATR)
  • RGEN 6.00
  • PARA 0.25
  • MACD
  • RGEN -0.77
  • PARA 0.01
  • Stochastic Oscillator
  • RGEN 13.86
  • PARA 77.04

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About PARA Paramount Global Class B

Paramount Global operates in three global business segments: TV media, filmed entertainment, and direct to consumer. The TV media business includes television production studios and various broadcast and cable networks, including CBS, 15 owned CBS affiliates, Paramount, Nickelodeon, MTV, BET, and VH1. Filmed entertainment consists multiple film studios, most importantly Paramount Pictures. The film studios produce and distribute movies that they license to movie theaters and other media outlets. Direct to consumer includes the Paramount+, Pluto TV, and BET+ streaming services. Much of the content on Paramount's streaming platforms is created by the production studios housed within the firm's other two business segments.

Share on Social Networks: